{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T04:58:23Z","timestamp":1791349103985,"version":"4.3.1"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.vaccine.2025.126844","type":"journal-article","created":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T22:37:11Z","timestamp":1739399831000},"page":"126844","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Evaluation of a nanoparticle influenza vaccine in the pig model"],"prefix":"10.1016","volume":"49","author":[{"given":"Pauline M.","family":"van Diemen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian Z.X.","family":"Lean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Ramsay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin C.","family":"Mollett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander M.P.","family":"Byrne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"N\u00fa\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleanor","family":"Herbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed M.","family":"Moin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle C.","family":"Crank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barney S.","family":"Graham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaru","family":"Kanekiyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen E.","family":"Everett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.vaccine.2025.126844_bb0005","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/s41573-019-0056-x","article-title":"Next-generation influenza vaccines: opportunities and challenges","volume":"19","author":"Wei","year":"2020","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.vaccine.2025.126844_bb0010","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3389\/fmicb.2018.00123","article-title":"Universal vaccines and vaccine platforms to protect against influenza viruses in humans and agriculture","volume":"9","author":"Raj\u00e3o","year":"2018","journal-title":"Front Microbiol"},{"issue":"2","key":"10.1016\/j.vaccine.2025.126844_bb0015","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/s41579-018-0115-z","article-title":"Host and viral determinants of influenza a virus species specificity","volume":"17","author":"Long","year":"2019","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.vaccine.2025.126844_bb0020","series-title":"Swine influenza a viruses and the tangled relationship with humans","volume":"11(3)","author":"Anderson","year":"2021"},{"key":"10.1016\/j.vaccine.2025.126844_bb0025","series-title":"Next-Generation Influenza Vaccines","volume":"11(8)","author":"Kanekiyo","year":"2021"},{"issue":"1","key":"10.1016\/j.vaccine.2025.126844_bb0030","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.chom.2018.06.016","article-title":"Overcoming barriers in the path to a universal influenza virus vaccine","volume":"24","author":"Coughlan","year":"2018","journal-title":"Cell Host Microbe"},{"issue":"12","key":"10.1016\/j.vaccine.2025.126844_bb0035","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens9121020","article-title":"Anti-influenza strategies based on nanoparticle applications","volume":"9","author":"Wieczorek","year":"2020","journal-title":"Pathogens"},{"issue":"5808","key":"10.1016\/j.vaccine.2025.126844_bb0040","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/290713a0","article-title":"Antigenic structure of influenza virus haemagglutinin defined by hybridoma antibodies","volume":"290","author":"Gerhard","year":"1981","journal-title":"Nature"},{"issue":"2 Pt 1","key":"10.1016\/j.vaccine.2025.126844_bb0045","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/0092-8674(82)90135-0","article-title":"The antigenic structure of the influenza virus a\/PR\/8\/34 hemagglutinin (H1 subtype)","volume":"31","author":"Caton","year":"1982","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.vaccine.2025.126844_bb0050","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1128\/JVI.06322-11","article-title":"Structural characterization of the hemagglutinin receptor specificity from the 2009 H1N1 influenza pandemic","volume":"86","author":"Xu","year":"2012","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2025.126844_bb0055","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1093\/ilar\/ilv002","article-title":"Swine as a model for influenza a virus infection and immunity","volume":"56","author":"Rajao","year":"2015","journal-title":"ILAR J"},{"key":"10.1016\/j.vaccine.2025.126844_bb0060","doi-asserted-by":"crossref","first-page":"347","DOI":"10.3389\/fvets.2018.00347","article-title":"Adaptation of human influenza viruses to swine","volume":"5","author":"Rajao","year":"2018","journal-title":"Front Vet Sci"},{"issue":"6","key":"10.1016\/j.vaccine.2025.126844_bb0065","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1177\/0300985812439724","article-title":"Kinetics of lung lesion development and pro-inflammatory cytokine response in pigs with vaccine-associated enhanced respiratory disease induced by challenge with pandemic (2009) a\/H1N1 influenza virus","volume":"49","author":"Gauger","year":"2012","journal-title":"Vet Pathol"},{"issue":"15","key":"10.1016\/j.vaccine.2025.126844_bb0070","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1016\/j.vaccine.2011.01.082","article-title":"Enhanced pneumonia and disease in pigs vaccinated with an inactivated human-like (\u03b4-cluster) H1N2 vaccine and challenged with pandemic 2009 H1N1 influenza virus","volume":"29","author":"Gauger","year":"2011","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2025.126844_bb0075","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.01725-21","article-title":"Vaccine-associated enhanced respiratory disease following influenza virus infection in ferrets recapitulates the model in pigs","volume":"96","author":"Kimble","year":"2022","journal-title":"J Virol"},{"issue":"41","key":"10.1016\/j.vaccine.2025.126844_bb0080","doi-asserted-by":"crossref","first-page":"6103","DOI":"10.1016\/j.vaccine.2018.08.072","article-title":"The type of adjuvant in whole inactivated influenza a virus vaccines impacts vaccine-associated enhanced respiratory disease","volume":"36","author":"Souza","year":"2018","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2025.126844_bb0085","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1099\/jgv.0.000468","article-title":"Vaccine-associated enhanced respiratory disease is influenced by haemagglutinin and neuraminidase in whole inactivated influenza virus vaccines","volume":"97","author":"Raj\u00e3o","year":"2016","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2025.126844_bb0090","doi-asserted-by":"crossref","first-page":"1253626","DOI":"10.3389\/fimmu.2023.1253626","article-title":"Heterologous prime-boost H1N1 vaccination exacerbates disease following challenge with a mismatched H1N2 influenza virus in the swine model","volume":"14","author":"Pliasas","year":"2023","journal-title":"Front Immunol"},{"issue":"7456","key":"10.1016\/j.vaccine.2025.126844_bb0095","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nature12202","article-title":"Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies","volume":"499","author":"Kanekiyo","year":"2013","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.vaccine.2025.126844_bb0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6602a1","article-title":"Prevention and control of seasonal influenza with vaccines: recommendations of the advisory committee on immunization practices - United States, 2017-18 influenza season","volume":"66","author":"Grohskopf","year":"2017","journal-title":"MMWR Recomm Rep"},{"issue":"4","key":"10.1016\/j.vaccine.2025.126844_bb0105","article-title":"Serologically-based evaluation of cross-protection antibody responses among different a(H1N1) influenza strains","volume":"8","author":"Marchi","year":"2020","journal-title":"Vaccines (Basel)"},{"issue":"2","key":"10.1016\/j.vaccine.2025.126844_bb0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0009068","article-title":"Replication, pathogenesis and transmission of pandemic (H1N1) 2009 virus in non-immune pigs","volume":"5","author":"Brookes","year":"2010","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.vaccine.2025.126844_bb0115","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/0264-410X(91)90125-P","article-title":"Principles of selective inactivation of viral genome. VI. Inactivation of the infectivity of the influenza virus by the action of beta-propiolactone","volume":"9","author":"Budowsky","year":"1991","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.126844_bb0120","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/978-1-4939-8678-1_4","article-title":"Propagation and titration of influenza viruses","volume":"1836","author":"Karakus","year":"2018","journal-title":"Methods Mol Biol"},{"issue":"10","key":"10.1016\/j.vaccine.2025.126844_bb0125","doi-asserted-by":"crossref","first-page":"6430","DOI":"10.1021\/acs.analchem.9b00095","article-title":"Development of a new tandem ion exchange and size exclusion chromatography method to monitor vaccine particle titer in cell culture media","volume":"91","author":"Shaddeau","year":"2019","journal-title":"Anal Chem"},{"issue":"1","key":"10.1016\/j.vaccine.2025.126844_bb0130","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1186\/s12917-020-02451-y","article-title":"The ARRIVE guidelines 2.0: updated guidelines for reporting animal research","volume":"16","author":"Percie du Sert","year":"2020","journal-title":"BMC Vet Res"},{"issue":"5","key":"10.1016\/j.vaccine.2025.126844_bb0135","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1750-2659.2010.00149.x","article-title":"Real time reverse transcription (RRT)-polymerase chain reaction (PCR) methods for detection of pandemic (H1N1) 2009 influenza virus and European swine influenza a virus infections in pigs","volume":"4","author":"Slomka","year":"2010","journal-title":"Influenza Other Respir Viruses"},{"key":"10.1016\/j.vaccine.2025.126844_bb0140","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/978-1-4939-0758-8_24","article-title":"Hemagglutinin inhibition assay with swine sera","volume":"1161","author":"Kitikoon","year":"2014","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.vaccine.2025.126844_bb0145","series-title":"The design of experiments: Statistical principles for practical applications","author":"Mead","year":"1990"},{"issue":"9","key":"10.1016\/j.vaccine.2025.126844_bb0150","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.3201\/eid2909.230066","article-title":"Interspecies transmission of swine influenza a viruses and human seasonal vaccine-mediated protection investigated in ferret model","volume":"29","author":"van Diemen","year":"2023","journal-title":"Emerg Infect Dis"},{"issue":"17","key":"10.1016\/j.vaccine.2025.126844_bb0155","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1016\/j.vaccine.2019.02.078","article-title":"Vaccine-mediated protection of pigs against infection with pandemic H1N1 2009 swine influenza a virus requires a close antigenic match between the vaccine antigen and challenge virus","volume":"37","author":"Everett","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.126844_bb0160","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/978-1-0716-0346-8_23","article-title":"Serum virus neutralization assay for detection and quantitation of serum neutralizing antibodies to influenza a virus in swine","volume":"2123","author":"Gauger","year":"2020","journal-title":"Methods Mol Biol"},{"issue":"12","key":"10.1016\/j.vaccine.2025.126844_bb0165","doi-asserted-by":"crossref","first-page":"5014","DOI":"10.4049\/jimmunol.1502632","article-title":"Aerosol delivery of a candidate universal influenza vaccine reduces viral load in pigs challenged with pandemic H1N1 virus","volume":"196","author":"Morgan","year":"2016","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2025.126844_bb0170","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01787-20","article-title":"Vaccines that reduce viral shedding do not prevent transmission of H1N1 pandemic 2009 swine influenza a virus infection to unvaccinated pigs","volume":"95","author":"Everett","year":"2021","journal-title":"J Virol"},{"issue":"200","key":"10.1016\/j.vaccine.2025.126844_bb0175","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3006366","article-title":"Vaccine-induced anti-HA2 antibodies promote virus fusion and enhance influenza virus respiratory disease","volume":"5","author":"Khurana","year":"2013","journal-title":"Sci Transl Med"},{"issue":"40","key":"10.1016\/j.vaccine.2025.126844_bb0180","doi-asserted-by":"crossref","first-page":"5170","DOI":"10.1016\/j.vaccine.2014.07.059","article-title":"Influenza a virus hemagglutinin protein subunit vaccine elicits vaccine-associated enhanced respiratory disease in pigs","volume":"32","author":"Raj\u00e3o","year":"2014","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.vaccine.2025.126844_bb0185","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/nm.3927","article-title":"Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection","volume":"21","author":"Yassine","year":"2015","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.vaccine.2025.126844_bb0190","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02810-18","article-title":"Design of Nanoparticulate Group 2 influenza virus hemagglutinin stem antigens that activate Unmutated ancestor B cell receptors of broadly neutralizing antibody lineages","volume":"10","author":"Corbett","year":"2019","journal-title":"mBio"},{"issue":"583","key":"10.1016\/j.vaccine.2025.126844_bb0195","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abe5449","article-title":"Broad neutralization of H1 and H3 viruses by adjuvanted influenza HA stem vaccines in nonhuman primates","volume":"13","author":"Darricarr\u00e8re","year":"2021","journal-title":"Sci Transl Med"},{"issue":"12","key":"10.1016\/j.vaccine.2025.126844_bb0200","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1016\/j.immuni.2022.10.015","article-title":"Co-immunization with hemagglutinin stem immunogens elicits cross-group neutralizing antibodies and broad protection against influenza a viruses","volume":"55","author":"Moin","year":"2022","journal-title":"Immunity"},{"issue":"692","key":"10.1016\/j.vaccine.2025.126844_bb0205","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.ade4790","article-title":"An influenza hemagglutinin stem nanoparticle vaccine induces cross-group 1 neutralizing antibodies in healthy adults","volume":"15","author":"Widge","year":"2023","journal-title":"Sci Transl Med"},{"issue":"12","key":"10.1016\/j.vaccine.2025.126844_bb0210","doi-asserted-by":"crossref","first-page":"6542","DOI":"10.1128\/JVI.00641-13","article-title":"Chimeric hemagglutinin influenza virus vaccine constructs elicit broadly protective stalk-specific antibodies","volume":"87","author":"Krammer","year":"2013","journal-title":"J Virol"},{"issue":"6254","key":"10.1016\/j.vaccine.2025.126844_bb0215","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1126\/science.aac7263","article-title":"A stable trimeric influenza hemagglutinin stem as a broadly protective immunogen","volume":"349","author":"Impagliazzo","year":"2015","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.vaccine.2025.126844_bb0220","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.chom.2020.07.006","article-title":"Surveillance of European domestic pig populations identifies an emerging reservoir of potentially zoonotic swine influenza a viruses","volume":"28","author":"Henritzi","year":"2020","journal-title":"Cell Host Microbe"},{"issue":"4","key":"10.1016\/j.vaccine.2025.126844_bb0225","doi-asserted-by":"crossref","first-page":"664","DOI":"10.3201\/eid2104.141375","article-title":"Severity of influenza a(H1N1) illness and emergence of D225G variant, 2013\u201314 influenza season, Florida, USA","volume":"21","author":"Iovine","year":"2015","journal-title":"Emerg Infect Dis J"},{"issue":"10","key":"10.1016\/j.vaccine.2025.126844_bb0230","doi-asserted-by":"crossref","first-page":"5949","DOI":"10.1128\/JVI.00545-13","article-title":"Molecular basis of the receptor binding specificity switch of the hemagglutinins from both the 1918 and 2009 pandemic influenza a viruses by a D225G substitution","volume":"87","author":"Zhang","year":"2013","journal-title":"J Virol"},{"issue":"28","key":"10.1016\/j.vaccine.2025.126844_bb0235","doi-asserted-by":"crossref","first-page":"4095","DOI":"10.1016\/j.vaccine.2018.05.086","article-title":"Identification of human vaccinees that possess antibodies targeting the egg-adapted hemagglutinin receptor binding site of an H1N1 influenza vaccine strain","volume":"36","author":"Garretson","year":"2018","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2025.126844_bb0240","doi-asserted-by":"crossref","first-page":"17735","DOI":"10.1038\/s41598-017-17986-8","article-title":"Diversity of antigenic mutants of influenza a(H1N1)pdm09 virus escaped from human monoclonal antibodies","volume":"7","author":"Yasuhara","year":"2017","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.vaccine.2025.126844_bb0245","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1010585","article-title":"Haemagglutinin substitutions N125D, D127E, D222G and R223Q improve replicative fitness and vaccine effectiveness of an a\/H1N1pdm09 live attenuated influenza vaccine virus by enhancing \u03b1-2,6 receptor binding","volume":"18","author":"Dempsey","year":"2022","journal-title":"PLoS Pathog"},{"issue":"1","key":"10.1016\/j.vaccine.2025.126844_bb0250","doi-asserted-by":"crossref","first-page":"10432","DOI":"10.1038\/s41598-018-28706-1","article-title":"The influenza virus hemagglutinin head evolves faster than the stalk domain","volume":"8","author":"Kirkpatrick","year":"2018","journal-title":"Sci Rep"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25001410?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25001410?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T11:19:07Z","timestamp":1741346347000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X25001410"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":50,"alternative-id":["S0264410X25001410"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.126844","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of a nanoparticle influenza vaccine in the pig model","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.126844","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"126844"}}